Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?

被引：0
|
作者：
Gianni, Caterina [1 ]
Nicolo, Eleonora [2 ]
Cristofanilli, Massimo [2 ]
机构：
[1] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Dept Med Oncol, Breast & GYN Unit, Meldola, Italy
[2] Weill Cornell Med, Div Hematol Oncol, Dept Med, 1300 York Ave, New York, NY 10065 USA
来源：
TRANSLATIONAL BREAST CANCER RESEARCH | 2024年 / 5卷
关键词：
CDK4/6; inhibitors; early breast cancer (EBC); ribociclib; hormone receptor positive (HR+); PLUS ENDOCRINE THERAPY; PALBOCICLIB;
D O I：
10.21037/tbcr-24-41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All
    Li, Jianbin
    CANCERS, 2025, 17 (04)
  • [2] CDK4/6 inhibitors in advanced hormone receptor-positive breast cancer
    Barroso-Sousa, Romualdo
    Tolaney, Sara M.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S205 - S209
  • [3] Willingness of women with early estrogen receptor-positive breast cancer to take adjuvant CDK4/6 inhibitors
    Lipton, N. J.
    Jesin, J.
    Warner, E.
    Cao, X.
    Kiss, A.
    Desautels, D.
    Jerzak, K. J.
    CURRENT ONCOLOGY, 2020, 27 (03) : 127 - 134
  • [4] Adjuvant CDK4/6 inhibitors: can they improve clinical outcomes in hormone receptor-positive (HR+) early breast cancer?
    Johnston, Stephen R. D.
    ANNALS OF PALLIATIVE MEDICINE, 2023,
  • [5] Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer
    Fang, Hehui
    Huang, Doudou
    Yang, Fang
    Guan, Xiaoxiang
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : CP8 - 297
  • [6] Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer
    Hehui Fang
    Doudou Huang
    Fang Yang
    Xiaoxiang Guan
    Breast Cancer Research and Treatment, 2018, 168 : 287 - 297
  • [7] CDK4/6 Inhibitors for Advanced Hormone Receptor-Positive Breast Cancer, 2019 and Beyond
    Layman, Rachel M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (02): : 190 - 192
  • [8] Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
    Scheidemann, Erin R.
    Shajahan-Haq, Ayesha N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [9] Efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive breast cancer: a systematic review and meta-analysis
    Ergun, Yakup
    Dogan, Mutlu
    Ucar, Gokhan
    Karacin, Pinar
    Karacin, Cengiz
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (17) : 1901 - 1909
  • [10] The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer
    Shah, Ami N.
    Cristofanilli, Massimo
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (01)
12345